Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,474
in 3 filings, $395K under 10b5-1 plans

Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-20 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +3,334 3,334
2023-06-30 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +28,308 28,308
2023-03-31 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +7,222 7,222
2022-12-30 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +2,536 2,536
2022-09-30 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +3,747 3,747
2022-06-30 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +26,837 26,837
2022-06-14 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2022-03-31 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +18,468 18,468
2021-12-31 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +7,943 7,943
2021-09-30 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +5,985 5,985
2021-06-30 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +3,985 3,985
2021-06-15 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +40,000 40,000

Page 1 of 1 · 12 trades